| Dr Michael Robert Kaczanowski, MD | |
|
8 Prospect St, North Ii, Nashua, NH 03060-3925 | |
| (603) 577-5355 | |
| (603) 577-5356 |
| Full Name | Dr Michael Robert Kaczanowski |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 23 Years |
| Location | 8 Prospect St, Nashua, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639371263 | NPI | - | NPPES |
| 3079568 | Medicaid | NH | |
| RE6661 | Other | NH | MEDICARE GROUP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 13968 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southern Nh Medical Center | Nashua, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Foundation Medical Partners Inc | 9436140456 | 280 |
News Archive
Expertise in mathematical sciences is playing an increasingly important role in professions beyond the classroom and academia, from aiding energy exploration and tracking disease outbreaks to creating high-tech simulations for the automotive, defense and aerospace industries.
Australia's federal government has announced that it will subsidize the cost of nicotine patches to help smokers quit. The announcement was made by Health Minister Nicola Roxon on Thursday who said that concession card holders would be able to access Nicorette, Nicabate P and Nicotinell under the Pharmaceutical Benefits Scheme (PBS) from February 1, 2011. She said, "Cancer scars the lives of too many Australians and we know that reducing the smoking rate is one of the most effective ways to reduce the rate of death from this terrible disease." Anti-smoking drug Varenicline (Champix) would also be available for willing quitters.
Nymox Pharmaceutical Corporation outlined today the Company's development program for the Company's lead drug candidate, NX-1207, currently in Phase 3 trials in the U.S. for the treatment of benign prostatic hyperplasia (BPH). The drug has been successful in a series of blinded controlled multi-center U.S. clinical trials where it has been found to produce improvements that are about double that reported for currently approved BPH drugs.
A George Mason University researcher is heading a scientific team that has received a sizable Department of Defense grant to combat the threat of a South American-borne disease that can cause long-term neurological problems and even death.
› Verified 7 days ago
| Entity Name | Foundation Medical Partners Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033162037 PECOS PAC ID: 9436140456 Enrollment ID: O20040519001048 |
News Archive
Expertise in mathematical sciences is playing an increasingly important role in professions beyond the classroom and academia, from aiding energy exploration and tracking disease outbreaks to creating high-tech simulations for the automotive, defense and aerospace industries.
Australia's federal government has announced that it will subsidize the cost of nicotine patches to help smokers quit. The announcement was made by Health Minister Nicola Roxon on Thursday who said that concession card holders would be able to access Nicorette, Nicabate P and Nicotinell under the Pharmaceutical Benefits Scheme (PBS) from February 1, 2011. She said, "Cancer scars the lives of too many Australians and we know that reducing the smoking rate is one of the most effective ways to reduce the rate of death from this terrible disease." Anti-smoking drug Varenicline (Champix) would also be available for willing quitters.
Nymox Pharmaceutical Corporation outlined today the Company's development program for the Company's lead drug candidate, NX-1207, currently in Phase 3 trials in the U.S. for the treatment of benign prostatic hyperplasia (BPH). The drug has been successful in a series of blinded controlled multi-center U.S. clinical trials where it has been found to produce improvements that are about double that reported for currently approved BPH drugs.
A George Mason University researcher is heading a scientific team that has received a sizable Department of Defense grant to combat the threat of a South American-borne disease that can cause long-term neurological problems and even death.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Robert Kaczanowski, MD 8 Prospect St, North Ii, Nashua, NH 03060-3925 Ph: (603) 577-5355 | Dr Michael Robert Kaczanowski, MD 8 Prospect St, North Ii, Nashua, NH 03060-3925 Ph: (603) 577-5355 |
News Archive
Expertise in mathematical sciences is playing an increasingly important role in professions beyond the classroom and academia, from aiding energy exploration and tracking disease outbreaks to creating high-tech simulations for the automotive, defense and aerospace industries.
Australia's federal government has announced that it will subsidize the cost of nicotine patches to help smokers quit. The announcement was made by Health Minister Nicola Roxon on Thursday who said that concession card holders would be able to access Nicorette, Nicabate P and Nicotinell under the Pharmaceutical Benefits Scheme (PBS) from February 1, 2011. She said, "Cancer scars the lives of too many Australians and we know that reducing the smoking rate is one of the most effective ways to reduce the rate of death from this terrible disease." Anti-smoking drug Varenicline (Champix) would also be available for willing quitters.
Nymox Pharmaceutical Corporation outlined today the Company's development program for the Company's lead drug candidate, NX-1207, currently in Phase 3 trials in the U.S. for the treatment of benign prostatic hyperplasia (BPH). The drug has been successful in a series of blinded controlled multi-center U.S. clinical trials where it has been found to produce improvements that are about double that reported for currently approved BPH drugs.
A George Mason University researcher is heading a scientific team that has received a sizable Department of Defense grant to combat the threat of a South American-borne disease that can cause long-term neurological problems and even death.
› Verified 7 days ago
Christopher Michael Riccio, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 17 Prospect St, Nashua, NH 03060 Phone: 603-594-6337 Fax: 603-594-6330 | |
Dr. Mark Liebling, Gastroenterology Medicare: Medicare Enrolled Practice Location: 166 Kinsley St Ste 301, Nashua, NH 03060 Phone: 603-883-5673 Fax: 603-689-1343 | |
Dr. Chengta Richard Dai, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 168 Kinsley Street, Suite 20, Nashua, NH 03060 Phone: 603-578-9363 Fax: 603-578-9539 | |
Dr. William Stephan, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 168 Kinsley St, Nashua, NH 03060 Phone: 603-889-4131 | |
Ihab M Ziada, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 173 Daniel Webster Hwy, Nashua, NH 03060 Phone: 603-891-4500 | |
Ajay K Sharma, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 8 Prospect St, Nashua, NH 03060 Phone: 603-577-2039 Fax: 603-882-5656 | |
Dr. Gianfranco Tulliano, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 8 Prospect St, Nashua, NH 03060 Phone: 603-577-2045 Fax: 603-577-5644 |